CD22/CD19 Dual-Target CAR-T Cells

BIOLOGICAL2 trials

Sponsors

Liping Dou

Conditions

B-cell Acute Lymphoblastic Leukemia

Phase 1

Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL

RecruitingNCT07575919

Liping DouB-cell Acute Lymphoblastic Leukemia

Start: 2026-01-01End: 2027-12-31Target: 20Updated: 2026-06-15

Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia

RecruitingNCT07575971

Liping DouB-cell Acute Lymphoblastic Leukemia

Start: 2026-01-01End: 2027-12-31Target: 30Updated: 2026-06-25